Gefcy 250 Tablet

Introduction to Gefcy 250 Tablet

Gefcy 250 Tablet is a medication primarily used to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is particularly effective for patients with certain genetic mutations in their cancer cells. This tablet is often prescribed to patients who have not undergone chemotherapy before.

Composition of Gefcy 250 Tablet

The active ingredient in Gefcy 250 Tablet is Gefitinib, which belongs to a class of drugs called EGFR tyrosine kinase inhibitors. This component plays a crucial role in blocking cancer cell growth.

Uses of Gefcy 250 Tablet

• Treatment of locally advanced non-small cell lung cancer (NSCLC).
• Effective for NSCLC with specific EGFR mutations.
• Prescribed for patients who have not received prior chemotherapy.

Side effects of Gefcy 250 Tablet

Common side effects:

• Diarrhea
• Skin rash
• Nausea
• Vomiting
• Loss of appetite

Serious side effects:

• Liver toxicity
• Lung inflammation
• Severe diarrhea leading to dehydration

Precautions of Gefcy 250 Tablet

Gefcy 250 Tablet should not be used by individuals without EGFR mutations, pregnant or breastfeeding women, or those with severe liver or kidney disease. It is also contraindicated for patients with a history of interstitial lung disease or allergies to Gefitinib or its ingredients.

How to Take Gefcy 250 Tablet

• Take one tablet orally once daily.
• Consume at the same time each day for consistency.
• Swallow the tablet whole with water, with or without food.

Conclusion of Gefcy 250 Tablet

Gefcy 250 Tablet is a targeted therapy for certain types of lung cancer, offering hope to patients with specific genetic profiles. While it can be highly effective, it is important to be aware of potential side effects and take necessary precautions. Always follow your healthcare provider's instructions when using this medication.